Expression of Adhesion Molecules on Myeloma Cells
Open Access
- 24 August 1996
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 87 (8) , 837-842
- https://doi.org/10.1111/j.1349-7006.1996.tb02108.x
Abstract
We investigated the expression of adhesion molecules including LFA‐1α (CD11a), Mac‐1 (CD11b), LFA‐1β (CD18), VLA‐β1, (CD29), H‐CAM (CD44), VLA‐4 (CD49d), VLA‐5 (CD49e), ICAM‐1 (CD54), N‐CAM (CD56), LFA‐3 (CD58), VNR‐β (CD61), and LECAM‐1 (CD62L) on fresh myeloma cells and human myeloma cell lines. By two‐color flow cytometric analysis with anti‐CD38 antibody, we demonstrated that myeloma cells were located in the strongly CD38‐positive (CD38++) fractions. Fresh myeloma cells were obtained from 28 patients with multiple myeloma (MM) and 3 patients with plasma cell leukemia (PCL). All myeloma cells expressed VLA‐4 on their surface. Most of the myeloma cells also expressed VLA‐5, ICAM‐1, and LFA‐3. H‐CAM was strongly expressed in 3 cases of PCL and 2 cases of aggressive myeloma, and moderately expressed in other MMs. N‐CAM was expressed in 68% of MMs, but none of the 3 PCLs. LFA‐1 was expressed in two cases of aggressive myeloma, but not expressed in other non‐aggressive myelomas. Most of the myeloma cells did not express Mac‐1, VNR‐β, or LECAM‐1. These results suggest that VLA‐4, VLA‐5, ICAM‐1, LFA‐3, and H‐CAM are involved in cellular interaction and migration in MM, and that the expression of N‐CAM and LFA‐1 varies with disease activity in MM.Keywords
This publication has 55 references indexed in Scilit:
- Adhesion molecules involved in the binding of murine myeloma cells to bone marrow stromal elementsInternational Journal of Cancer, 1995
- Cell adhesion receptors on neoplastic plasma cellsAmerican Journal of Hematology, 1995
- Cell surface expression and functional significance of adhesion molecules on human myeloma‐derived cell linesBritish Journal of Haematology, 1994
- Discordant LFA-1/ICAM-1 expression in a case of secondary plasma cell leukemia associated with subcutaneous plasmacytomaAmerican Journal of Hematology, 1993
- Effects of lnterleukin-3 and lnterleuki-6 on Peripheral Blood Cells from Multiple Myeloma Patients and Their Clinical SignificanceActa Haematologica, 1992
- Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cellsBritish Journal of Haematology, 1991
- Expression of the neural cell adhesion molecule (CD56) by human myeloma cellsClinical and Experimental Immunology, 1991
- Immunophenotypic Analysis of Lymphocytes and Myeloma Cells in Patients with Multiple MyelomaActa Haematologica, 1990
- Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma.The Journal of Experimental Medicine, 1989
- Endothelial cell receptors on leukemic plasma cellsLeukemia Research, 1989